Lantheus Holdings Inc (LNTH)

NASDAQ HEALTHCARE
$103.86 +0.65% RSI 63 Neutral Add Alert

Moving Averages

SMA 200
$69.65
Price above

Company Profile

Lantheus Holdings, Inc. develops, manufactures and markets diagnostic and therapeutic agents and products that assist physicians in the diagnosis and treatment of heart, cancer and other diseases worldwide. The company is headquartered in North Billerica, Massachusetts.

Sector
HEALTHCARE
Industry
DRUG MANUFACTURERS - SPECIALTY & GENERIC
Market Cap
$6.73B
P/E Ratio
24.67
EPS
$4.19
Beta
-0.043
Dividend Yield
0.00%
52-Week High
$104.57
52-Week Low
$47.25

Similar stocks in DRUG MANUFACTURERS - SPECIALTY & GENERIC

HIMS
Hims & Hers Health Inc - Class A
RSI 64.0
CGC
Canopy Growth Corporation
RSI 37.0
BFRI
Biofrontera Inc
RSI 55.0
TLRY
Tilray Brands Inc - Class 2
RSI 33.0
ACB
Aurora Cannabis Inc
RSI 32.0
BCRX
Biocryst Pharmaceuticals Inc
RSI 55.0
INM
InMed Pharmaceuticals Inc
RSI 59.0
ORGO
Organogenesis Holdings Inc - Class A
RSI 50.0
ZTS
Zoetis Inc - Class A
RSI 57.0
AQST
Aquestive Therapeutics Inc
RSI 52.0

Data last updated: June 13, 2026 at 8:10 AM EDT

Track LNTH for free

Get e-mail RSI alerts when Lantheus Holdings Inc enters oversold or overbought territory. Free forever.

Add Alert